Don't miss out on hearing real-life examples and shared industry experience to make the most of your clinical trial budget, meet timelines and maximise productivity.
Ensure that you make the most of your Phase II and III clinical trials - attend and benefit from:
Annick Derwael, Clinical Development Manager Oncology, GlaxoSmithKline, Belgium
Yves Geysels, President, ACRP, Belgium
Maurizio Salvi, Head of Secretariat EGE, European Commission, Belgium
Dr. Fraser Inglis, Consultant Physician & Director, Glasgow Memory Clinic, UK
Dr. Timothy Hagerty, Ph.D., M.B.A., Head of Business Analysis, Roche Pharma AG, Germany
Patricia Otto-Terlouw, M.Sc, Associate Director Clinical Program Management, Global Clinical Science, Astellas Pharma, The Netherlands
Stephen Porter, Pharm.D., Chief Scientific Officer, Dragon Bio-Consultants Ltd., Hong Kong
Christine Schwenninger, Head Global Clinical Monitoring, Actelion Pharmaceuticals, Switzerland
Ludger Buehrmann, Head Regional Monitoring, Clinical research, GlaxoSmithKline, Germany
David Liens, Chief Medical officer, Erytech Pharma, France
Alessandro Matano, Statistician, Novartis Pharma AG, Switzerland
James Denmark, Founder & CEO, myClin, USA
John Illingworth, Managing Director, Illingworth Research Ltd & ResearchNurses.co. UK
Michael Kracht, Owner, CDC - Clinical Development Consulting, Germany
Michael Zoerer, Group Leader Clinical Operations, AOP Orphan, Austria
Antoon Tielemans, Outsourcing Manager, Bristol-Myers Squibb, Belgium
PRE-CONFERENCE SYMPOSIUM W – Tuesday 22nd May
Risk-Based Monitoring: Design and implementation
Led By: Liz Wool, CCRA, CMT, President & CEO, QD-Quality and Training Solutions Inc., USA
Featuring: Ludger Buehrmann, GlaxoSmithKline; Patricia Otto-Terlouw, Astellas Pharma & Dr. Fraser Inglis, Glasgow Memory Clinic
DOWNLOAD THE LATEST AGENDA FOR FURTHER DETAILS OF THIS MUST ATTEND SYMPOSIUM
"Good conference specific for clinical operations and good opportunity to network"
"Overall good conference with good ideas, understanding and networking"
"Good chance to network and seek suppliers"
"Excellent speakers and content of material"
"Good content and some fresh view points"
Download the Latest Agenda - Updated 5 Jan 2011

keep up with the latest developments for this summit and network with others in this area by joining the dedicated LinkedIn Group here